

Fundamental dimension Equity attribute | CECOPeer $57.49▲+1.36% Cap $3.37BP/E -98.8x QuantScore47/100 | CLHLeader $318.76▼-0.69% Cap $16.83BP/E 38.5x QuantScore53/100 | DCIPeer $84.79▼-1.54% Cap $9.82BP/E 21.6x QuantScore49/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
95/100 |
26/100 |
Valuation Multiples, PEG & DCF upside | 31/100 | 29/100 | 73/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 55/100 | 78/100 |
Growth Revenue / earnings growth & margins | 79/100 | 18/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 73/100 | 70/100 | 36/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -98.8x | 38.5x | 21.6x |
Forward P/E (next FY) | 25.0x | 31.6x | 19.6x |
EV / EBITDA (TTM) | 130.4x | 16.0x | 15.0x |
Price / Sales | 3.7x | 2.7x | 2.5x |
Price / Free Cash Flow | -295.6x | 86.5x | 23.0x |
PEG ratio | 0.71 | 2.49 | 0.82 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 7 / 9 | 7 / 9 |
Altman Z-Score | 1.58 (Distress) | 3.92 (Safe) | 5.47 (Safe) |
Total debt / equity | 0.37 | 1.04 | 0.78 |
Quick ratio | 1.2x | 1.8x | 1.4x |
Interest coverage | 0.4x | 4.3x | 16.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +38.8% | +2.4% | +5.3% |
Net income growth YoY | +286.3% | -2.8% | +23.7% |
Gross margin (TTM) | 32.7% | 26.6% | 34.6% |
Operating margin (FY) | 6.7% | 11.2% | 15.4% |
FCF margin (FY) | -0.7% | 7.3% | 11.0% |
5. Trailing price performancePrice change over period |
1M return | -21.1% | +0.9% | -2.1% |
3M return | -24.0% | +4.9% | -8.6% |
6M return | -11.4% | +3.2% | -4.7% |
Year to date | -3.9% | +35.9% | -4.4% |
1Y return | +10.2% | +29.9% | +1.8% |
3Y return | +270.2% | +105.1% | +44.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $44.54 -22.5% premium | $121.81 -61.8% premium | $68.43 -19.3% premium |
Wall Street consensus target | $106.80 +85.8% · range $85.00–$125.00 | $363.70 +14.1% · range $335.00–$390.00 | $96.50 +13.8% · range $91.00–$105.00 |
Consensus stance | 71% Buy29% Hold-0% Sell | 68% Buy32% Hold-0% Sell | 36% Buy43% Hold21% Sell |